Please provide your email address to receive an email when new articles are posted on . Transcranial magnetic stimulation targets the central executive network. 80% of patients responded by 20 ...
InvestorsHub on MSN
Brainsway Shares Jump After FDA Extends Deep TMS Approval to Teen Depression
Brainsway Ltd. (NASDAQ:BWAY) saw its stock pop 5% in premarket trading Thursday after securing a key FDA label expansion for its Deep Transcranial Magnetic Stimulation (Deep TMS) system, clearing the ...
Credit: BrainsWay. The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to induce electrical currents in localized regions of the prefrontal cortex. Real-world ...
Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access to non‑drug mental health treatments BURLINGTON, Mass. and JERUSALEM, April 15, 2026 (GLOBE ...
BrainsWay (BWAY) announced recent positive pilot data from an independent, third-party study conducted at Stanford University evaluating an accelerated protocol using the Company’s Deep Transcranial ...
NEW YORK, March 13, 2026 /PRNewswire/ -- Radial today announced publication of a landmark study showing accelerated Deep TMS can treat depression in six days instead of months. The research evaluated ...
Moment of Clarity has published a new educational resource titled “How Deep TMS Therapy Works,” providing a comprehensive overview of transcranial magnetic stimulation (TMS) and its emerging role in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results